Transcranial Direct Current Stimulation for Post-Stroke Aphasia
NCT ID: NCT02461355
Last Updated: 2019-05-09
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
2 participants
INTERVENTIONAL
2015-06-30
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Transcranial Direct Current Stimulation in Post-stroke Aphasia
NCT02622945
TDCS and Aphasia Therapy in the Acute Phase After Stroke
NCT03297450
Transcranial Direct Current Stimulation (tDCS) in Chronic Post-Stroke Apathy
NCT02915484
TDCS in Acute Stroke
NCT01701713
Evaluating Anodal tDCS Preceding Aphasia Therapy
NCT02249819
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Anodal tDCS
Anodal tDCS over the left posterior language areas during aphasia therapy for 8 one-hour sessions
Aphasia therapy
Aphasia therapy using a computerized scripting program
Anodal tDCS
Anodal transcranial direct current stimulation using the Chattanooga Ionto device
Sham tDCS
Sham tDCS over the left posterior language areas during aphasia therapy for 8 one-hour sessions
Aphasia therapy
Aphasia therapy using a computerized scripting program
Sham tDCS
Sham transcranial direct current stimulation using the Chattanooga Ionto device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Aphasia therapy
Aphasia therapy using a computerized scripting program
Anodal tDCS
Anodal transcranial direct current stimulation using the Chattanooga Ionto device
Sham tDCS
Sham transcranial direct current stimulation using the Chattanooga Ionto device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Ischemic left hemispheric stroke verified by imaging (CT or MRI) greater than 6 months ago
3. Residual non-fluent or anomic aphasia, with Western Aphasia Battery-Revised Aphasia Quotient score \<60
4. Fluent English speaker prior to stroke
5. Right-handed prior to stroke
6. Ability to give informed consent and understand the tasks involved.
Exclusion Criteria
2. Imaging unavailable
3. Large middle cerebral artery infarct involving entire inferior division (temporo-parietal) territory
4. History of dementia prior to the stroke
5. History of seizure, prior electroconvulsive therapy, deep brain stimulators, or brain surgery
6. Social and/or personal circumstances that interfere with ability to return for therapy and assessment sessions.
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pitkin Foundation
UNKNOWN
Columbia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tomoko Kitago, MD
Role: PRINCIPAL_INVESTIGATOR
Columbia University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Adler Aphasia Center
Maywood, New Jersey, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AAAO1700
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.